Metraipolis › archive › dc_99ccf599984e

Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: a phase IV, single-arm, open-label, multicenter study — Europe PMC PMID:41163043

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41163043
DOI
10.1186/s13023-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-08T23:26:14.626Z
SHA-256 of the archived text
09008258766da84cdd446852276e2a593e056184009eb2f54ef6d13c39b2d053
Stable URL of this page
https://metraipolis.com/documento/dc_99ccf599984e

How to cite

Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: a phase IV, single-arm, open-label, multicenter study — Europe PMC PMID:41163043 — Europe PMC (en), https://europepmc.org/article/MED/41163043 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99ccf599984e (Metraipolis archive dc_99ccf599984e, sha256 09008258766da84cdd446852276e2a593e056184009eb2f54ef6d13c39b2d053)
BibTeX
@misc{dc99ccf599984e,
  title = {Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: a phase IV, single-arm, open-label, multicenter study — Europe PMC PMID:41163043},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41163043},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99ccf599984e; sha256 09008258766da84cdd446852276e2a593e056184009eb2f54ef6d13c39b2d053},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41163043. Agents can read the archived copy with the MCP tool read_document.